-
Je něco špatně v tomto záznamu ?
Signal transducer and activator of transcription 3 signaling in tumor immune evasion
L. Zhang, K. Kuca, L. You, Y. Zhao, K. Musilek, E. Nepovimova, Q. Wu, W. Wu, V. Adam
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
- MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádorové mikroprostředí MeSH
- signální transdukce MeSH
- transkripční faktor STAT3 * metabolismus MeSH
- únik nádoru z imunitní kontroly * MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
The underlying mechanism of tumor immune evasion is a highly concerning subject for researchers. Increasing evidences reveal that the over-activated signal transducer and activator of transcription 3 (STAT3) is a crucial molecular hub in malignant tumors. STAT3 controls autophagy molecules that impair CTL-mediated tumor cell lysis, inhibiting natural killer cells and inducing apoptosis in T lymphocytes to create an immunosuppressive environment. STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to establish a tolerant tumor microenvironment (TME). STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to create an immunosuppressive environment. All this aid tumor cells in escaping from immune surveillance. In this review, we outlined the STAT3-mediated mechanisms involved in tumor immune evasion and their potential regulatory functions in the TME. We discussed the impact of STAT3 signaling on PD-L1, HIF-1α, exosome, lncRNA, and autophagy in the promotion of tumor immune evasion and highlighted the recent research on STAT3 signaling and tumor immune evasion that may assist in developing effective STAT3-targeted drugs for advancing immunotherapy.
Central European Institute of Technology Brno University of Technology Brno 602 00 Czech Republic
College of Life Science Yangtze University Jingzhou 434025 China
Department of Chemistry and Biochemistry Mendel University in Brno Brno 613 00 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011217
- 003
- CZ-PrNML
- 005
- 20220506130326.0
- 007
- ta
- 008
- 220425s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.pharmthera.2021.107969 $2 doi
- 035 __
- $a (PubMed)34450232
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Zhang, Luying $u College of Life Science, Yangtze University, Jingzhou 434025, China
- 245 10
- $a Signal transducer and activator of transcription 3 signaling in tumor immune evasion / $c L. Zhang, K. Kuca, L. You, Y. Zhao, K. Musilek, E. Nepovimova, Q. Wu, W. Wu, V. Adam
- 520 9_
- $a The underlying mechanism of tumor immune evasion is a highly concerning subject for researchers. Increasing evidences reveal that the over-activated signal transducer and activator of transcription 3 (STAT3) is a crucial molecular hub in malignant tumors. STAT3 controls autophagy molecules that impair CTL-mediated tumor cell lysis, inhibiting natural killer cells and inducing apoptosis in T lymphocytes to create an immunosuppressive environment. STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to establish a tolerant tumor microenvironment (TME). STAT3 signaling regulates the expression of immune factors and recruits immunosuppressive cells to create an immunosuppressive environment. All this aid tumor cells in escaping from immune surveillance. In this review, we outlined the STAT3-mediated mechanisms involved in tumor immune evasion and their potential regulatory functions in the TME. We discussed the impact of STAT3 signaling on PD-L1, HIF-1α, exosome, lncRNA, and autophagy in the promotion of tumor immune evasion and highlighted the recent research on STAT3 signaling and tumor immune evasion that may assist in developing effective STAT3-targeted drugs for advancing immunotherapy.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a transkripční faktor STAT3 $x metabolismus $7 D050796
- 650 _2
- $a signální transdukce $7 D015398
- 650 12
- $a únik nádoru z imunitní kontroly $7 D019139
- 650 _2
- $a nádorové mikroprostředí $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 500 03, Czech Republic
- 700 1_
- $a You, Li $u College of Life Science, Yangtze University, Jingzhou 434025, China
- 700 1_
- $a Zhao, Yingying $u College of Life Science, Yangtze University, Jingzhou 434025, China
- 700 1_
- $a Musilek, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 500 03, Czech Republic
- 700 1_
- $a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 500 03, Czech Republic
- 700 1_
- $a Wu, Qinghua $u College of Life Science, Yangtze University, Jingzhou 434025, China; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 500 03, Czech Republic. Electronic address: wqh212@hotmail.com
- 700 1_
- $a Wu, Wenda $u MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China; Department of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Králové 500 03, Czech Republic. Electronic address: wuwenda@njau.edu.cn
- 700 1_
- $a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno 613 00, Czech Republic; Central European Institute of Technology, Brno University of Technology, Brno 602 00, Czech Republic. Electronic address: vojtech.adam@mendelu.cz
- 773 0_
- $w MED00006662 $t Pharmacology & therapeutics $x 1879-016X $g Roč. 230, č. - (2022), s. 107969
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34450232 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130318 $b ABA008
- 999 __
- $a ok $b bmc $g 1789028 $s 1162415
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 230 $c - $d 107969 $e 20210824 $i 1879-016X $m Pharmacology & therapeutics $n Pharmacol Ther $x MED00006662
- LZP __
- $a Pubmed-20220425